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YemenStigma is synonymous with leishmaniasis, an endemic deadly ﬂesh-eating disease in Yemen that affects
predominantly poor rural women and children. Women with leishmaniasis often present late and experi-
ence not only physical deformities and the risk of death, but also the painful stigma of the disease and its
consequences, a similar situation to that of leprosy decades ago. The International Society of Dermatolo-
gy–sponsored community dermatology project Eradication of Leishmaniasis from Yemen Project has
made a difference in the leishmaniasis situation in Yemen and addressed its magnitude. The program erad-
icated leishmaniasis from some areas, dealt with and improved its alarming prevalence among children
and women who are the neglected and highest risk groups, and solved some issues associated with poor
access to proper drugs. Medicine donation has enabled women with leishmaniasis to freely receive medi-
cine they otherwise would not have been able to afford, reduced their mortality and morbidity, and mini-
mized the extensive impact the socio-aesthetic stigma has on their lives. Our cause has attracted local and
global attention to these problematic issues.
© 2016 The Author. Published by Elsevier Inc. on behalf of Women's Dermatologic Society. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Leishmaniasis is a groupof protozoandiseases, caused by Leishmania
parasites, transmitted by the bite of some species of sand ﬂy. It ranks
third in disease burden in disability-adjusted life years caused by
neglected tropical diseases and is the second most frequent cause of
parasite-related deaths after malaria (Boer et al., 2011; Peter, 2008).
Cutaneous leishmaniasis (CL) is generallymild butmay cause cos-
metic disﬁgurement. Mucocutaneous leishmaniasis (MCL) and vis-
ceral leishmaniasis (VL) are associated with signiﬁcant morbidity
and mortality. If left untreated, the fatality rate of VL is as high as
100%; in some areas, the case fatality rate is three times higher in
women than in men because of gender inequality (Desjeux, 2004).
Leishmaniasis constitutes the greatest threat to the health and so-
cioeconomic status of women as a gender and social group in Yemen.
The clinical course and results of infections are generally different in
women because exposure to infection may be related to behavior
and work patterns of males and females, which are frequentlyInc. on behalf of Women's Dermdistinct. Immunity to infection and response to treatment may differ
between the sexes, and pregnancy alters susceptibility to infection
(Brabin and Brabin, 1992).Leishmaniasis—a hidden disease in Yemen
Leishmaniasis,which has been neglected for decades, is an serious
endemic disease, but the true epidemiological data were
underestimated. There was a huge disconnect between physicians
and patients in the knowledge of leishmaniasis, and it was difﬁcult
to ﬁnd a doctor who could properly diagnose or treat leishmaniasis
(Canizares, 1986; World Health Organization, 2006).Hidden victims
Yemeni leishmaniasis patients had been suffering from neglect,
improper diagnosis, maltreatment, lack of affordability, and the
shortage of appropriate medicine. Once afﬂicted, patients suffered
from serious complications, including death without a recorded
cause. The situation is similar to that of leprosy decades ago.atologic Society. This is an open access article under the CC BY-NC-ND license
94 M.A. Al-Kamel / International Journal of Women's Dermatology 2 (2016) 93–101Yemeniwomen, particularly ruralwomen, are considered a neglected
group that receives less attention and greater restrictions than they de-
serve. They are more vulnerable to skin disease and suffer greater social
stigma than men. The prevalence of leishmaniasis is the highest among
rural adult females and male children (Al-Kamel, 2015; 2016).
Objectives
This article represents a personal account of the impact of leishman-
iasis on women in Yemen based on my 13 years of experience treating
affected patients, with an update onmy International Society of Derma-
tology (ISD)-supported initiative to combat leishmaniasis in Yemen.
Impact of leishmaniasis in Yemeni women
Synonyms
Stigma is synonymous with leishmaniasis disease in Yemen.
“Bada’h,” “Oﬁyah,” “Atharah,” and “Shegnah” are the most common
names that I identiﬁed that are used to refer to the leishmaniasis dis-
ease skin lesion in the endemic regions of Yemen. All of these terms
mean apparent lingering residual or life-long stigma (Al-Kamel, 2015).
Impact upon women’s physical health and well-being
Most of the women with leishmaniasis present late with severe
symptoms, such as mucosal involvement or huge ulcerative-crusted
plaques or nodules, mainly but not exclusively on their faces. Others
present with unwanted complications such as disseminations, perfo-
rated or deformed nose, disﬁgured lips, infected ulcers, big ugly scars,
or even malignant transformation (Figs. 1 and 2). Children with VL
usually present very latewithmassive hepatosplenomegaly, substan-
tial weight loss, and anemia; some of them die even through the dis-
ease is under treatment (Fig. 3) (Al-Kamel, 2015).Fig. 1.Yemeni female childrenwith (A)mucocutaneous leishmaniasis (MCL) complicated by
(C) giant CL plaque on the right cheek, and (D) destructive MCL ulcer on the lower lip who w
city; and Radaa, a district of the Al Baydaa governorate in central Yemen.Families from some endemic districts in Al Baydaa, Hajjah, and
Sana’a governorates reported many cases of children and adult
womenwithVL symptoms. Somehadbeendiagnosed asmalignancies;
others died without diagnoses after undertaking long trips to receive
medical, nonmedical, and popular treatments. Yemeni women express
more concern about their physical appearance, but leishmaniasis-
related aesthetic stigma often depresses their sense of body satisfac-
tion, limits their mobility, and leads to poor physical health.
In brief, deformity, disability, lifelong disﬁguring scarring, general
health deterioration, and the risk of death are the most common
health consequences in Yemeni women with leishmaniasis.Impact upon women’s sociocultural concepts
Depending on the level of deformities and disﬁguring scars,
Yemeni women with leishmaniasis receive enacted, perceived, or
self-stigma with different levels of discrimination. Stigmatization
often affects all aspects of women’s lives, especially interpersonal re-
lationships, social activities, work capacity, and, ﬁnally, marriage in a
community in which much of their role and identity is based upon
marriage and the ability to give birth to children. To my knowledge,
cases of divorce on the grounds of the disease have never been re-
ported, but the potential for risk of divorce could be taken in consid-
eration. Some affected wives often experience a stressed marriage,
and girls encounter many difﬁculties in getting married.
Although leishmaniasis may, in fact, be infectious but not conta-
gious in a person-to-person sense (with rare exceptions of congenital
transmission of VL from mother to child upon birth, or during blood
transfusions), some mothers with leishmaniasis have tried keeping
themselves away from their children for fear of infecting them.
Most ruralwomenwear face veils; thus, some of the stigma, espe-
cially of facial lesions in uncovered women, is associated with the
blame-the-victim idea that if thewoman had beenmodestly covered,
she would not have been infected.stigmatizing nasal perforation, (B) lepromatous diffuse cutaneous leishmaniasis (DCL),
ere treated at the Regional Leishmaniasis Control Center’s clinics in Sana’a, the capital
Fig. 3. Two female children with visceral leishmaniasis granted free medicine at the Regional Leishmaniasis Control Center’s Hajjah unit at the north of Yemen.
Fig. 2. Aesthetic stigma associated with mucocutaneous leishmaniasis in adult Yemeni females, at the Regional Leishmaniasis Control Center clinics in Yemen.
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stigma inﬂicts upon affected women is the most destructive power
in their lives.Impact upon women’s psychological well-being
Women with leishmaniasis who complain of social stigmatization
anddiscriminationusually experiencedecreased self-esteem, emotional
stress, and anxiety that may predispose them to psychiatric morbidity.Impact upon women’s economic opportunities
To afford treatment, some affected rural women attempt to avoid
potentially stigmatizing situations; others havebeen forced to sell valu-
able assets, thereby signiﬁcantly increasing their level of poverty.
Leishmaniasis-related stigma limits their mobility and working capac-
ity both inside and outside the home. Girls and women who became
isolated on the grounds of leishmaniasis usually face destitution.Fig. 4. (A) Dr. Mohamed Al-Kamel treating female child with leishmaniasis. (B) A young g
Yemen Project volunteer at RLCC’s Radaa clinic.Risk factors for Yemeni women
I identiﬁed the following gender-speciﬁc factors that may intensi-
fy the spread and impact of leishmaniasis in populations of Yemeni
women (Al-Kamel, 2015):
1. Children and women represent the sector suffering the
greatest deﬁciencies of medical care. They have poor access
to proper drugs for leishmaniasis, which are unaffordable and
often unavailable in pharmacies and even in the public health
stores. The excess of females over males in rural endemic
areas, inherited social habits, and a perceived inability to ob-
tain a proper diagnosis and treatment are also factors. The
last of these may encourage women to try more kinds of treat-
ment, such as self-treatment and local healers’ methods.
2. Late presentation thatmight be a result of lack of healthcare ac-
cess, a sort of gender inequality in preferential treatment in
rural and tribal communities, or the social stigma associated
with the disease that keeps females hidden may accentuate
leishmaniasis morbidity and mortality.irl with leishmaniasis granted free medicine by an Eradication of Leishmaniasis from
97M.A. Al-Kamel / International Journal of Women's Dermatology 2 (2016) 93–1013. Most womenwith late presentation depend exclusively on unsafe
popular therapies, such as corrosive chemicals and topical steroids.
4. Almost all women displayed a lack of essential knowledge
about the disease’s nature and etiology and primary protective
measures.
5. Poverty, which ismore aggressive among rural femaleswhodo
not have any source of income except that obtained from their
families' sponsor males.
6. Keeping livestockwithinhumanhabitationsmaintains a leishman-
iasis reservoir andvector that ismuch closer to thehumanhost, es-
pecially women who spend most of their time inside houses.
7. It has been speculated that much of the observed excess of
leishmaniasis in adult females and male children may derive
from habitual gender- and age-speciﬁc occupational roles.
Most boys and women work in agriculture and animal care
and are responsible for procuring water, especially at dusk
and in the early morning, which increase their exposure to
sand ﬂy bites.Fig. 5. Eradication of Leishmaniasis from Yemen Project remote ﬁeld’s educationa8. There is a high illiteracy rate among rural Yemeni females. Analysis
of the 2005 YemenHousehold Budget Survey (HBS) indicated that
rural women, irrespective of poverty status, have literacy rates
around25%,whereasevenpoorurbanwomenhave twice the liter-
acy rate (World Bank, 2014).Myths and beliefs
A lot ofmyths and false beliefs surrounding leishmaniasis have been
reported.Many oldwomen referred to leishmaniasis as a divine punish-
ment, the devil touch, and so on. Some believed that the lesion is highly
contagious, and others associated it with water or air pollution.
My initiative to combat leishmaniasis in Yemen
To confront the dire need for action to implement effective leish-
maniasis surveillance and control, my ISD-sponsored communityl, surveillance, and treatment campaigns to many endemic regions of Yemen.
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Project (ELYP) took place in January 2013 as the ﬁrst and most
effective community movement against leishmaniasis in the history
of the disease in Yemen.
The ﬁrst phase of ELYP included the foundation of the Regional
Leishmaniasis Control Center (RLCC) in Sana’a in April 2013, with a
grant from the American Academy of Dermatology. Subsequently,
three more units were established at Al Baydaa, Ibb, and Hajjah
governorates (Figs. 1-4).
ELYP had strategies to address and eradicate leishmaniasis from
Yemen, support needy patients, and improve patients’ lives. The
program depended on effective awareness raising and educational,
surveillance, treatment, control, and research programs. Bringing
global attention to the burden of leishmaniasis in Yemen and the
issues of women and children were its main objectives.
Achievements
Within a short period after its announcement, four regional units/
clinics were established, 100 volunteers were engaged, remote ﬁeld
campaigns (Figs. 5 and 6) to more than 62 endemic villages and settle-
ments in 6 governorates were organized, andmore than 1,050 patients
received free diagnosis and treatment services (including parenteral
and intralesional antimonial injections, topical and oral antifungal and
antibacterial medications, surgery, electrocautery, and cryotherapy).
During remote ﬁeld visits, an average of 10 to 50 hidden leishmaniasis
patients in each village, all inhabitants were infected in some villages,
and some families with all members’ being infected were recorded. All
Yemeni population sectors have beneﬁted frommore than 30,000 cop-
ies of awareness-raising newsletters; hand brochures and wall posters;Fig. 6. Somemethods ELYP's andRLCC's staff use to raise the awareness for leishmaniasis and
Mogali, Hajjah unit); (B) teaching public healthworkers (Dr. Zakaria, Hajjah unit); (C-D) teac
ofﬁcials; and (F) TV and mass media (Al Jazeera Channel).meetings and workshops; mobile teledermatology tool; and mass
media educational ﬂashes, programs, and television episodes.
In August 2014, ELYP organized the ﬁrst RLCC Conference that
was accompanied by a Medicine-For-All Program launching ceremo-
ny, under the slogan “insuring medicine for the poor” in Sana’a. The
conference attracted the people of interest and media from Yemen
and the world (Fig. 7).
Together with the ISD executive members for 2013, ISD success-
fully lobbied Stiefel/GlaxoSmithKline (GSK) to provide a compassion-
ate supply of anti-leishmaniasismedication (Pentostam injections) to
this project over three years. In 2014, the International League of Der-
matological Societies considerately awarded RLCC a grant, supported
by the ISD, for laboratory diagnostic equipment.
Many research activities have been conducted at RLCC that have
addressed and reported the burden of leishmaniasis in Yemen, its im-
pact on women and children as the populations at the highest risk,
and the issues associated with poor access to anti-leishmanial
drugs. This research as aimed to ﬁnd effective solutions.
Burden estimates of leishmaniasis in Yemen upon ELYP
The magnitude of leishmaniasis infection in Yemen is alarming.
RLCC estimated the prevalence of leishmaniasis in Yemen as average
of 180,000 patients in June 2013 (0.72% of the population, as captured
and collected with ELYP initiative through RLCC outpatient clinics’
databases and surveillance campaigns in the endemic governorates
during the same period) (Al-Kamel, 2013).
There are no solid data on the incidence of Leishmania infections in
Yemen, but the disease is certainly underreported, especially inwomen
and children, and may exceed 10,000 cases per year (Ali, 2011).combat its related stigma in Yemen: (A) teaching school students (Dr. Al-Kamel andDr.
hing teachersworkshops (Dr. Al-Arhabi, Ibb unit); (E)meetingswithMinistry ofHealth
Fig. 7. Dr. Mohamed Al-Kamel, Dr. Luitgard Wiest, and Dr. Ahmed Alanisey speaking at the ﬁrst Regional Leishmaniasis Control Center Congress in Sana’a, August 13, 2014.
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Fig. 8. Overall prevalence of leishmaniasis by age and sex group. Source: Al-Kamel, 2015.
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Fig. 9. Prevalence of different clinical forms of leishmaniasis among study population. Source: Al-Kamel, 2015.
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published literature based on research conducted at the RLCC:
1. Leishmaniasis is the most common parasitic infestation and
the most prevalent infectious disease in central Yemen, with
an overall prevalence of 4.11% among all detected skin diseases
(Al-Kamel, 2016).
2. CL, MCL, and VL have signiﬁcant endemicity in Yemen, and Al
Bayda is themost endemic governorate. Incidence of leishman-
iasis is highest among rural children and female populations
(90.1%) (Figs. 1-3) and is higher among adult females (Fig. 2)
than adult males (Fig. 8). MCL seems to be the most prevalent
form (49.3%) and occurs more frequently among females than
males. It is followed by CL (47.4%), then VL (3.3%) (Fig. 9). The
most prevalent Leishmania strains are Leishmania major, Leish-
mania tropica, Leishmania infantum, and Leishmania donovani.
The incidence of leishmaniasis infection peaks in August (au-
tumn), and the majority of patients belong to poor farming
families (Al-Kamel, 2015).
Impact of medicine donation
Although sodium stibogluconate antimony (Pentostam) is the
drug of choice, this medicine is usually unavailable, and when avail-
able is costly and unaffordable for poorer leishmaniasis patients.
The mean relative cost of a treatment regimen for an adult woman
is USD 200, USD 100 for a child.
Stiefel/GSKPentostamdonation helped ELYP in offeringneedypa-
tients, particularly women, a free, relatively safe, and highly effective
drug they otherwise would not have been able to afford. Donations
are estimated to reach an average of 1,500 patients.
After the ﬁrst year (October 2014–December 2015) and despite
the conditions of war, 348 patients have beneﬁted from the
Pentostam donation: 90.43% were rural inhabitants, 48.85% females,
62.64% under the age of 12 years, 54.89% with CL, 39.94% with MCL,
and 5.17% with deadly VL (Table 1). Most of the patients (47%)Table 1
RLCC: Leishmaniasis Patients Who Beneﬁted from Stiefel/GSK Pentostam Donation for
the First Year (October 2014-December 2015).
Diagnosis Females Males Total %
Cutaneous leishmaniasis 96 95 191 54.89%
Mucocutaneous leishmaniasis 68 71 139 39.94%
Visceral leishmaniasis 6 12 18 05.17%
Total 170 178 348 100.00%
Source: Al-Kamel, 2014, 2015.were granted themedicine at the RLCC’s Al Baydaa unit in Radaa dis-
trict, and the majority of patients came from Al Baydda, Sana’a,
Hajjah, Dhamar, Raimah, Ibb, Mahweet, Amran, and Taiz governor-
ates, respectively (Al-Kamel, 2014). Moreover, in response to ELYP’s
recommendation and concurrently with its generousmedicine dona-
tion, Stiefel/GSK reduced the price of Pentostam injections in the local
pharmaceutical market to enable competent patients purchasing the
medicine.
Despite the fact that access to these medicines has signiﬁcantly
improved and high curative rates have been achieved, 6.51% of pa-
tients showed resistance, intolerability, or an allergy to this drug’s in-
gredients; thus, the need for alternative drugsmay be imperative (Al-
Kamel, 2014).
It was reported that the prevalence of leishmaniasis in some vil-
lages in central Yemen, where the disease remained a signiﬁcant
problem up to September 2014, has been remarkably reduced to
zero at the end of 2015.
Medicine donation through our Medicine-For-All Program has
had a great impact on affected women: It has saved and improved
their lives, reduced deformities, minimized the impact of
leishmaniasis-related stigma and its psychosocial consequences,
and improved the situation of what was considered a hidden dis-
ease in Yemen.
Lasting impact of ELYP
Despite the scarcity of resources, war, and instability, ELYP has
made a difference in the leishmaniasis situation in Yemen. To my
knowledge, for the ﬁrst time, we have addressed the magnitude of
the disorder and eradicated it from some areas in central Yemen.
We have dealt with and improved its alarming prevalence among
children and women, who are among the neglected and highest
risk groups. Issues associated with poor access to proper drugs were
solved. Our cause has attracted local and global attention to these
problematic issues.
Thanks to RLCC’s volunteers, awareness of the disease thatwas near
to zero has been signiﬁcantly increased in the community. Now, most
physicians in rural and urban health units are aware of and interested
in the disease and have at least the essential knowledge in how to diag-
nose,manage, and refer leishmaniasis patients. As a result, the research
capabilities of leishmaniasis in Yemen have improved.
Impact of the war conditions and displacement of populations
The ongoingwar in Yemen (started inMarch 2015) forced us to
close the head RLCC unit in Sana’a for 3 months (April-June 2015),
restricted our ability to effect more ﬁeld campaigns, and
101M.A. Al-Kamel / International Journal of Women's Dermatology 2 (2016) 93–101prevented some leishmaniasis patients from reaching our centers.
It has been observed that the war pushed millions of big city in-
habitants out to villages, where leishmaniasis is endemic. Current-
ly, increased numbers of leishmaniasis cases whowere considered
urban inhabitants before the war are seen. I have noticed that
wounds in injured ﬁghters represent easy meals for leishmaniasis
vectors (female sand ﬂies). Given the substantial growth of popu-
lations of dogs, rodents, feral cats, and ﬂies in the cities, I expect a
future increase in leishmaniasis among the urban populations
who were considered the lowest risk groups (International Socie-
ty of Dermatology, 2016).
If women are not educated to provide for themselves and take
care of their own needs, they are at risk as they lose the protection
of the men who are caught up with the war. It also would affect
both adults and children in being able to go to school and to get
health examinations to detect disease at an earlier stage.Recommendations
ELYP faces an imperative need to offer alternative medications,
such as meglumine antimonite (Glucantime), Amphotericin B,
miltefosine, and paromomycin to those who cannot tolerate sodium
stibogucanate antimonials. Cost and availability should not be obsta-
cles preventing poor rural women from accessing anti-leishmanial
medicines.
The next phase of partnership with project ELYP should include,
in addition to further medicine donation, the possibility of medical
staff training, molecular diagnosistics, clinical research sponsorships,
disﬁgured women’s rehabilitation program, and improvement of ac-
cess to our services for populations living in remote areas. ELYP’s sur-
veillance, educational, and management remote ﬁeld campaigns are
in need of vehicles and camping capabilities. Public investment in
our research, educational, treatment, and control programs would
decrease the leishmaniasis local and global burden.
Yemen is often left out of maps of the worldwide distribution of
leishmaniasis. These maps should be redrawn regularly considering
the alarmingmagnitude of leishmaniasis in Yemen, one of its endem-
ic countries.Conﬂict of interest disclosure
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